You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 3, 2024

Aurobindo Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?

AUROBINDO has four hundred and ninety-two approved drugs.

There are nineteen tentative approvals on AUROBINDO drugs.

Summary for Aurobindo

US Patents:	0
Tradenames:	372
Ingredients:	346
NDAs:	492
Patent Litigation for Aurobindo:	See patent lawsuits for Aurobindo
PTAB Cases with Aurobindo as petitioner:	See PTAB cases with Aurobindo as petitioner

Drugs and US Patents for Aurobindo

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Ltd	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	202038-002	Sep 28, 2012	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma Ltd	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	202633-003	Oct 26, 2012	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma Ltd	PARICALCITOL	paricalcitol	CAPSULE;ORAL	207672-002	Jan 14, 2016	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma	FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	209116-001	Oct 30, 2017		OTC	No	No		⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma	ATOMOXETINE HYDROCHLORIDE	atomoxetine hydrochloride	CAPSULE;ORAL	079016-004	May 30, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma	FENOFIBRATE	fenofibrate	TABLET;ORAL	216798-001	Sep 27, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma	CEPHALEXIN	cephalexin	CAPSULE;ORAL	065253-002	Nov 16, 2005	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Aurobindo

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aurobindo Pharma Usa	MAXZIDE-25	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-003	May 13, 1988	4,444,769	⤷ Try a Trial
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,105,783	⤷ Try a Trial
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,444,769	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for AUROBINDO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.